Initial results with [F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis.

Unlabelled: Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial lung disease with a poor prognosis. Ga-labeled FAP ligands exhibited highly promising results due to the crucial role of activated fibroblasts in fibrosis imaging of the lung. However, F-labeled FAP ligands might provide qualitatively much higher imaging results with accompanying economic benefits due to large-scale production.

Histopathology of the idiopathic interstitial pneumonias (IIP): A review.

The 2013 American Thoracic Society/European Respiratory Society consensus classification update of the idiopathic interstitial pneumonias (IIP) included several important modifications to the organization and spectrum of the diseases that were proposed in an earlier multidisciplinary consensus document in 2002. The histopathology of the now 'major' and 'rare' IIP is presented here with exposition of the newly included entity of a distinctive upper lobe fibrotic lung disease referred to as idiopathic pleuroparenchymal fibroelastosis. The 'rare histological patterns' of acute fibrinous and organizing pneumonia and bronchiolocentric patterns of interstitial pneumonia are illustrated and discussed.

[Pneumonia in the inmunocompromised host: perspective through images diagnosis and a Bayesian inference].

Introduction: The population of immunocompromised patients has increased in recent decades. Many of these patients eventually present infectious complications including pneumonia, which is a diagnostic that must to be prompt and accurate.

Objective: To review the basis of the diagnosis of pneumonia in the immunocompromised patient.

[Survival of patients with biopsy-proven idiopathic pulmonary fibrosis: Chilean National Thorax Institute experience].

Background: Idiopathic Pulmonary Fibrosis (IPF) is the most prevalent of all interstitial lung diseases. The usual underlying pathological picture is an interstitial pneumonia (UIP).

Aim: To describe the evolution of a Chilean cohort of patients with IPF.

[Cyanoacrylate pulmonary embolism after embolization of a cerebral arteriovenous malformation. Report of one case].

Arterial embolization with cyanoacrylate is commonly used for the treatment of arteriovenous malformations. We report the case of a 40 years old man who four days after an embolization with cyanoacrylate, begins with cough, bloody sputum, and right hemithorax pleuritic pain. Pulmonary embolism was confirmed with chest X ray, CT scan and scyntigraphy.